Marie-Eve Robinson

Investigator, CHEO Research Institute

Dr. Marie-Eve Robinson is a pediatric endocrinologist at the Children’s Hospital of Eastern Ontario, as well as a clinician investigator and assistant professor at the University of Ottawa. She holds a University of Ottawa Clinical Research Chair in Genetic Skeletal Disorders. She is the scientific director of SkeleTal Research on Novel Genes Program (STRONG Program), which aims to better characterize the phenotype of rare genetic bone disorders and identify new candidate genes associated with such disorders. Additional studies focus on drug therapy in osteogenesis imperfecta. Dr. Robinson is involved in national and international efforts to advance knowledge on pediatric bone diseases. She is the co-chair of the Canadian Consortium on Children’s Bone Health (CCCBH), a national network of Canadian pediatric endocrinologists working with children with pediatric bone disorders.

She is the chair of a subcommittee of the Pediatric Endocrine Society (PES) Bone and Mineral Interest Group aiming at identifying knowledge gaps and advancing pediatric bone health knowledge among pediatric endocrinologists across North America. Finally, she is involved in outreach programs aimed at improving the care of children with osteogenesis imperfecta living in developing countries such as Ecuador and Haiti.

Related News

Research Projects

  1. Standardized growth charts for children with osteogenesis imperfecta


    Our standardized OI type- and sex-specific growth charts can be used to assess the growth of individuals with OI from infancy to adulthood.

  2. Mitigating the Denosumab‑Induced Rebound Phenomenon with Alternating Short‑ and Long‑Acting Anti‑resorptive Therapy in a Young Boy with Severe OI Type V


  3. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy


    Readily measurable clinical variables were associated with prevalent VF in males with glucocorticoid-treated DMD. These variables may be useful to identify candidates for primary osteoporosis prevention after glucocorticoid initiation.

  4. Dominant osteogenesis imperfecta with low bone turnover caused by a heterozygous SP7 variant


  5. Motivational Interviewing and the Use of Psychological Services Among Youth With Chronic


    All specialized pediatricians have a role to play in ensuring that at-risk youth with CMCs receive the psychiatric support they need.